UHN's New Cyclotron
A new cyclotron, currently being readied for use, will soon be creating medical isotopes to be used for radiation scanning strategies as part of The Princess Margaret Cancer Program. Among the uses will be the detection and visualization of cancers, helping The Princess Margaret Cancer Centre lead the way in Personalized Cancer Medicine.
» Read the full story
New Cancer Drug receives approval for Phase One Human Trial
A new cancer drug created by research teams led by Dr. Tak Mak of The Campbell Family Cancer Research Institute & Dr. Dennis Slamon from UCLA, has received approval from both Health Canada and the Food and Drug Administration (FDA) in the US to proceed to Phase One Clinical Trial.
» Read more about the new sharpshooter drug
The Immune Therapy Program at the Princess Margaret Cancer Centre draws from the basic science and clinical strengths of one of the top 5 cancer research centres in the world. Led by an award-winning team of researchers and physicians, The Princess Margaret is positioned to become one of the global leaders in Immune Therapy for cancer treatment.
Watch to hear how Dr. Pam Ohashi is leading the way:
Find out more about Immune Therapy
RESEARCH IN FOCUS
Led by Dr. John Dick, Cancer researchers discover pre-leukemic stem cell at root of AML, relapse
Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia (AML).
» Read more...
Stem cell scientists identify key regulator controlling formation of blood-forming stem cells
Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online in Cell.
» Read More